Multiple Myeloma, Amyloidosis and Waldenström Macroglobulinemia | Addressing Current Questions and Controversies in the Management of Multiple Myeloma, Amyloidosis and Waldenström Macroglobulinemia
Proceedings from Part 2 of a 2-part satellite symposia series
during the 61st ASH Annual Meeting. Featuring perspectives from Drs
Jesús G Berdeja, Sagar Lonial, María-Victoria Mateos, Nikhil C
Munshi, Robert Z Orlowski and Noopur Raje.
Introduction
Program Overview: Dr Love (00:00)
Up-Front Management of Multiple Myeloma
(MM)
Case (Dr Peswani): A woman in her early 70s
who achieves a VGPR to induction RVd but is unwilling to undergo
ASCT (01:08)
Case (Dr Khan): A woman in her mid-80s with
IgG lambda MM and poor renal function (07:00)
Faculty Presentation: Dr Raje (20:51)
Consolidation and Maintenance Therapy; Emerging Role of
Minimal Residual Disease
Case (Dr Brenner): A man in his early 50s with
Stage III IgG lambda MM and t(14;16) (33:39)
Case (Dr Lamar): A woman in her late 70s
presents with renal failure, is diagnosed with MM and receives
CyBorD (38:01)
Faculty Presentation: Dr Munshi (43:40)
Current Management of Relapsed/Refractory
MM
Case (Dr Brenner): A man in his late 60s
experiences a biochemical relapse while receiving lenalidomide
maintenance after RVd and ASCT (59:22)
Additional questions from the community oncologist/hematologist
panel regarding the management of relapsed/refractory MM
(1:02:22)
Faculty Presentation: Dr Mateos (1:06:40)
Novel Strategies Under Investigation for the Treatment
of MM
Case (Dr Brenner): A man in his late 80s with
t(11;14) MM and multiple comorbidities experiences disease
progression on second-line pomalidomide/daratumumab/dexamethasone
(1:19:25)
Faculty Presentation: Dr Lonial (1:21:52)
Therapeutic Strategies Targeting B-Cell Maturation
Antigen in MM
Case (Dr Lamar): A man in his late 40s with
high-risk MM experiences rapid disease progression on RVd
(1:39:10)
Faculty Presentation: Dr Berdeja (1:42:24)
Amyloidosis and Waldenström Macroglobulinemia
(WM)
Case (Dr Khan): A woman in her late 50s with
multiple comorbidities is diagnosed with renal amyloidosis and
receives up-front CyBorD (2:08:32)
Case (Dr Lamar): A fit man in his early 90s
who has been observed for 4 to 5 years for WM (2:14:02)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.